OncologyInformationService
Real World Databases
Evidence based Healthcare and Market Research
O.I.s) has become
TriNetX Oncology GmbH,
our new website is coming soon!
Why choose O.I.s)
Expert in Oncology
Expert in Healthcare Market Research
Warranty of Quality
International Team
Solutions
Decision Finder
Real World Data (TherapieMonitor)
Real World Evidence (Non-Interventional studies)
Evidence based Market Assessment & Dynamics (OncoRegioPanel)
Epidemiology, Healthcare Structure Research
References
Publications
Endorsements
Team
O.I.s) Team
Want to join us?
Current Projects
TherapieMonitor (RealWorldData)
TherapieMonitor Multiples Myelom 1. Quartal 2023
TherapyMonitor Leucemia Linfocítica Crónica (LLC) 2021-2022
OncoPanel
OncoPanel des mCRC & KHT im 1. Quartal 2023
Barometer
Patient Reported Outcomes
COVID-19-Pandemie: Patientenbefragung 2020
Patienten-App MM: Patientenbefragung 2019
Are you interested to participate?
Imprint
Publikation
Disparities in Access to EGFR‐Mutation Testing in Patients with Advanced NSCLC in Germany 2011
Lenka Kellermann, Dieter Ukena The results were presented in a poster at the ISPOR Annual European Congress 2012. -->
PDF